Diagnosis Technology Articles & Analysis: Older
10 news found
Confidence in finding lifesaving cures is at an all-time high among medical researchers who work tirelessly for a solution. Astounding technological advancements and breakthroughs in the past decade mean we can expect to dramatically shift the cancer diagnosis, treatment and prevention paradigm. ...
Intin has been recognized for its outstanding design and engineering in healthcare technology. Diagnosis & treatment at home for respiratory conditions Intin's innovation not only diagnoses respiratory ailments but also helps get proper treatment. With the 'Oview Multi Device,' anyone can receive a diagnosis of respiratory conditions and ...
A recent study confirms the high accuracy of the Uscom BP+ central blood pressure monitor for detection of the dangerous cardiac rhythm abnormality Atrial Fibrillation (AF) in a primary care setting. This result confirms that BP+ suprasystolic oscillometry is 94% effective for detection of AF in home care environments and may be used as a screening investigation. ...
CARB-X is awarding Accelerate Diagnostics, a Tucson, Arizona, USA, biotech company, up to US$578,000 to develop new fiber optic technology to diagnose sepsis or the risk of sepsis. Accelerate would be eligible for up to $2.1 million in additional funds from CARB-X if the project meets certain milestones, subject to available funds. ...
Scivita Medical's product covers both flexible endoscopy and rigid endoscopy, and has unique advantages in the research and commercialization of all cutting-edge technologies in the field of medical endoscopes. It has ultra-high-definition visualization technology (such as 4K UHD visualization), 3D visualization technology, special light ...
Imperative Care, Inc., a company singularly dedicated to answering unsolved problems in stroke, today announced that Matthew Garrett has been appointed as the company’s Chief Financial Officer. Mr. Garrett is a seasoned finance and operations executive who brings more than 20 years of industry leadership experience and an extensive track record of scaling public and private healthcare ...
Eligibility is restricted to innovative medical devices that provide more effective treatment or diagnosis of life-threatening conditions, where there are no approved or cleared alternatives, and where early device availability is in the best interests of patients. ...
Inflammatix, a pioneering molecular diagnostics company delivering precision medicine at the point of care, today announced the appointment of João Fonseca, Ph.D., as Chief Technology Officer. Dr. Fonseca will oversee Inflammatix’s molecular assay development and engineering teams as the company advances its rapid tests for acute infections, sepsis, and COVID-19 risk stratification. ...
“Although this is an emerging technology, these results show that OA/US technology could help deliver more timely, actionable cancer diagnoses for millions of women,” said Gisela Menezes, MD, PhD, medical director at Seno Medical. “When time is of the essence, this technology could give physicians and their patients the ...
GE (NYSE: GE) has announced the formation of the “GE Healthymagination Fund”, a new equity fund that will make investments in highly promising healthcare technology companies. The fund will invest in companies globally that have innovative diagnostic, IT, and life sciences technologies aligned with the strategic objectives of GE’s Healthymagination initiative. ...